In addition, they also indirectly shift the balance between tumor reactivity and tumor tolerance by recruiting through e.g. CCL3, CCL4, and CCL5 as well as be promoting the induction of T cell-suppressive Tregs through the release of IL-10 or TGF-β [363], among others. The gene discussed is CCL5; the disease is neoplasm.